Toba Isaac Olatoye

Toba Isaac Olatoye

Auto-generated profile, based on publicly available information

Toba Isaac Olatoye

Department of Biochemistry, University of Ilorin P.M.B. 1515, Ilorin, Kwara State, Nigeria

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2025 in JMIRx Bio
Verified
Journal Article
Open access
TOToba Isaac Olatoye
Toba Isaac Olatoye
Background: Cholesterol biosynthesis is a critical pathway in cellular metabolism, with 3-hydroxy-3-methylglutaryl coenzyme-A reductase (HMGR) catalyzing its committed step. HMGR inhibition has been widely explored as a therapeutic target for managing hypercholesterolemia, and statins are the most commonly used competitive inhibitors. However, the search for novel, natural HMGR inhibitors remains a vital area of research, due to the adverse effects associated with long-term statin use. Cochlospermum planchonii and Cochlospermum tinctorium are West African medicinal plants traditionally used to treat metabolic disorders, including dyslipidemia. Despite their usefulness, the specific bioactive compounds responsible for these effects are currently poorly characterized, justifying further investigations. Objective: This study investigates the potential of phytochemicals from Cochlospermum planchonii and Cochlospermum tinctorium as natural inhibitors of human HMGR using molecular docking techniques. Methods: A total of 84 phytochemicals from 2 species of Cochlospermum as reported in literature, were evaluated as potential inhibitors of HMGR. Using DataWarrior software, their drug-likeness and ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) properties were screened in accordance with Lipinski’s Rule of Five. The 32 compounds that met the criteria were docked on PyRx against the HMG-binding site of HMGR, alongside atorvastatin (native ligand) and 6 known statins, which served as control ligands. Results: Docking analysis of their two best binding modes showed that 10 (31.3%) out of the 32 screened phytochemicals demonstrated strong binding affinities and interactions with the HMG-binding pocket (residues 682‐694) of HMGR, with binding energy (ΔG) scores ranging from −4.6 to −6.0 kcal/mol, comparable to or exceeding those of statins (−4.6 to −5.7 kcal/mol). Their docking scores (−13.272 to −32.103) also compared favorably with those of statins (−25.939 to −36.584). Interestingly, 3-O-methylellagic acid (ID_13915428) demonstrated the strongest interaction, forming 26 binding interactions with the HMG-binding pocket residues, more than any compound, including statins. One-way ANOVA of the mean and SEM of the binding affinity scores for the phytochemicals and statins (9 replicates each) indicated a statistically significant difference at P<.05 (total sample size n=153; actual P=.0001). Conclusions: This study is the first to virtually screen and identify specific bioactive compounds isolated from Cochlospermum planchonii and Cochlospermum tinctorium with potential cholesterol-lowering effects in humans. The findings not only support the traditional use of these plants in West Africa to manage dyslipidemia and other ailments, but also present the phytochemicals as promising drug candidates for further optimization as natural inhibitors of HMGR. However, while this study provides valuable computational insights into the molecular interactions of the compounds with HMGR, further advanced computational, in vitro, and in vivo studies are still necessary to validate their inhibitory potential and therapeutic applications.

22 January 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
TOToba Isaac Olatoye
Toba Isaac Olatoye
Cholesterol biosynthesis is a critical pathway in cellular metabolism, with 3-hydroxy-3-methylglutaryl coenzyme-A reductase (HMGR) catalyzing its committed step. The inhibition of HMGR has been widely explored as a therapeutic target for managing hypercholesterolemia, and statins are the most commonly used competitive inhibitors. However, the search for novel, natural inhibitors of HMGR is still a vital area of research, especially in light of the adverse effects of the prolonged use of statins. In this study, the potential of 84 phytochemicals isolated from two species of Cochlospermum (C. planchonii and C. tinctorium) reported in the literature, was investigated as novel inhibitors of human HMGR using molecular docking techniques. The phytochemicals were screened for their drug-likeness and ADMET properties in accordance with Lipinski’s rule of five, and 32 of them were docked against the HMG-binding portion of the enzyme’s active site, together with its native ligand and 6 known statins serving as control ligands. The docking results revealed that 10 of the compounds exhibited strong binding affinities and interactions with the HMG-binding pocket of the enzyme, comparable to or exceeding those of the control ligands. This evidence strongly suggests their potential as effective inhibitors of HMGR. For the first time, the findings from this research identify and directly implicate the specific bioactive compounds of C. planchonii and C. tinctorium capable of exerting cholesterol-lowering effects in humans, while validating previously reported studies on the efficacy of these plants’ extracts used in West African traditional medicine to manage dyslipidemia, among a host of other ailments. The compounds identified may serve as promising drug candidates which can be further optimized and developed as novel, natural inhibitors of HMGR.

23 April 2025 in JMIRx Bio
Verified
Journal Article
Open access
SSSylvester Sakilay
Sylvester Sakilay
MCMitchell Collier
Mitchell Collier
ARArya Rahgozar
Arya Rahgozar
TOToba Olatoye
Toba Olatoye
SSSimon Muhindi Savai
Simon Muhindi Savai
JMJulie Moonga
Julie Moonga


3 March 2025 in JMIRx Med
Verified
Journal Article
Open access
DSDaniela Saderi
Daniela Saderi
SRShailee Rasania
Shailee Rasania
TOToba Olatoye
Toba Olatoye
SSSimon Muhindi Savai
Simon Muhindi Savai
Randa Salah Gomaa MahmoudRanda Salah Gomaa Mahmoud
Randa Salah Gomaa Mahmoud
MCMitchell Collier
Mitchell Collier
This is a peer review report related to MS ID#69472

13 June 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
TOToba Isaac Olatoye
Toba Isaac Olatoye
JAJoseph O. Adebayo
Joseph O. Adebayo
Benzene is known to cause myelotoxicity which impacts secondary complications mediated by oxidative stress on the heart and erythrocyte. Gallic acid is an antioxidant which has not been evaluated for protective effect against cardiovascular complications of benzene-induced myelotoxicity. Therefore, this study was carried out to evaluate the effects of gallic acid on the concentrations of selected oxidative stress biomarkers and activities of antioxidant enzymes in the erythrocyte and heart of mice with benzene-induced myelotoxicity. Thirty-six male mice were randomized into six groups of six mice each. Group A served as the normal control receiving distilled water while the remaining groups were orally administered 150 mg/kg body weight of benzene for fourteen days. Distilled water, 50 mg/kg body weight of ascorbic acid, 25, 50, and 100 mg/kg body weight of gallic acid were simultaneously administered to mice of groups B (negative control), C, D, E, and F respectively for fourteen days. Concentrations of oxidative stress biomarkers and activities of antioxidant enzymes in target tissues were then determined. Results revealed significant elevation (p<0.05) in the concentrations of malondialdehyde, nitric oxide and protein carbonyl, as well as significant decrease (p<0.05) in the concentrations of reduced glutathione, protein, and activities of catalase, glutathione peroxidase, glutathione-S-transferase and superoxide dismutase in the heart and erythrocyte of negative control compared to normal control. However, treatment with gallic acid at various doses significantly reverted (p<0.05) the observed alterations in these parameters, comparing favourably with ascorbic acid (reference drug). These results suggest that gallic acid protected the heart and erythrocyte against lipid and protein oxidation, and enhanced antioxidant defense system of mice with benzene-induced myelotoxicity. Keywords: myelotoxicity; oxidative stress; gallic acid; ascorbic acid; benzene; antioxidant enzymes; biomarkers; lipid peroxidation; protein oxidation.